The ‘Counterfeit’ conundrum in pharma industry – Is it time for concerted action? – The Financial Express

0

The latest World Health Organisation (WHO) initiative on Substandard/Spurious/Falsely-labelled/ Falsified/ Counterfeit medical products has been making slow but steady progress through meetings in 2012, 2013 and the latest on October 29-31, 2014. A technically strong delegation comprising four seniormost drug regulators from (DCSO/DCGI) office represented India.

Read more – The Financial Express

 

share >>>
December 22, 2014 |

Leave a Reply

Vantage Theme – Powered by WordPress.
Skip to toolbar